18F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard A Systematic Review

被引：5

作者：

Seierstad, Therese ^{[1
]}

Hole, Knut Hakon ^{[1
,2
]}

Tulipan, Andreas Julius ^{[1
,2
]}

Stromme, Hilde ^{[3
]}

Lilleby, Wolfgang ^{[4
]}

Revheim, Mona-Elisabeth ^{[1
,2
]}

Hernes, Eivor ^{[1
]}

机构：

[1] Oslo Univ Hosp, Div Radiol & Nucl Med, POB 4956 Nydalen, N-0424 Oslo, Norway

[2] Univ Oslo, Inst Clin Med, POB 1171 Blindern, N-0318 Oslo, Norway

[3] Univ Oslo, Lib Med & Sci, Sognsvannsveien 20, N-0372 Oslo, Norway

[4] Oslo Univ Hosp, Dept Oncol, POB 4953 Nydalen, N-0424 Oslo, Norway

来源：

PET CLINICS | 2021年 / 16卷 / 02期

关键词：

Prostate cancer; PSMA; PET/CT; PET/MR imaging; Personalized medicine; Fluciclovine PET; Histopathology; POSITRON-EMISSION-TOMOGRAPHY; ANTI-1-AMINO-3-F-18-FLUOROCYCLOBUTANE-1-CARBOXYLIC ACID; DIAGNOSTIC PERFORMANCE; CARCINOMA; EXPERIENCE; PET/MRI; SAFETY;

D O I：

10.1016/j.cpet.2020.12.012

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

The PET tracer 18F-fluciclovine (Axumin) was recently approved in the United States and Europe for men with suspected prostate cancer recurrence following prior treatment. This article summarizes studies where systematic sector-based histopathology was used as reference standard to assess the diagnostic accuracy of the tracer 18F-fluciclovine PET in patients with prostate cancer. © 2021 The Authors

引用

页码：167 / 176

页数：10

共 50 条

[1] 18F-Fluciclovine PET in Recurrent Prostate Cancer
不详
JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (04) : 17N - 17N
[2] Review of 18F-Fluciclovine PET for Detection of Recurrent Prostate Cancer
Gusman, Mariya
Aminsharifi, Jamie A.
Peacock, Justin G.
Anderson, Shane B.
Clemenshaw, Michael N.
Banks, Kevin P.
RADIOGRAPHICS, 2019, 39 (03) : 822 - 841
[3] 18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review
Soroush Rais-Bahrami
Jason A. Efstathiou
Catriona M. Turnbull
Stephen B. Camper
Andy Kenwright
David M. Schuster
Andrew F. Scarsbrook
Prostate Cancer and Prostatic Diseases, 2021, 24 : 997 - 1006
[4] 18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review
Rais-Bahrami, Soroush
Efstathiou, Jason A.
Turnbull, Catriona M.
Camper, Stephen B.
Kenwright, Andy
Schuster, David M.
Scarsbrook, Andrew F.
PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (04) : 997 - 1006
[5] Update on 18F-Fluciclovine PET for Prostate Cancer Imaging
Parent, Ephraim E.
Schuster, David M.
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (05) : 733 - 739
[6] 18F-fluciclovine PET or PSMA PET for prostate cancer imaging?
Baris Turkbey
Peter L. Choyke
Nature Reviews Urology, 2020, 17 : 9 - 10
[7] PROSTATE CANCER 18F-fluciclovine PET or PSMA PET for prostate cancer imaging?
Turkbey, Baris
Choyke, Peter L.
NATURE REVIEWS UROLOGY, 2020, 17 (01) : 9 - 10
[8] The role of 18F-fluciclovine PET in the management of prostate cancer: a systematic review and meta-analysis
Kim, S. J.
Lee, S. W.
CLINICAL RADIOLOGY, 2019, 74 (11) : 886 - 892
[9] Detection of Recurrent Prostate Cancer With 18F-Fluciclovine PET/MRI
Selnaes, Kirsten Margrete
Kruger-Stokke, Brage
Elschot, Mattijs
Johansen, Hakon
Steen, Per Arvid
Langorgen, Sverre
Aksnessaether, Bjorg Yksnoy
Indrebo, Gunnar
Sjobakk, Torill Anita Eidhammer
Tessem, May-Britt
Moestue, Siver Andreas
Knobel, Heidi
Tandstad, Torgrim
Bertilsson, Helena
Solberg, Arne
Bathen, Tone Frost
FRONTIERS IN ONCOLOGY, 2020, 10
[10] Letter regarding "18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review"
Parent, Ephraim E.
PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (04) : 944 - 945

← 1 2 3 4 5 →